Cagrilintide

Long-acting amylin receptor agonist. Investigated for its role in satiety signaling and studied in combination with GLP-1 agonists in metabolic and obesity research.

Peptides China supplies Cagrilintide as lyophilized powder in sealed vials synthesized at ≥98% purity and verified by HPLC and mass spectrometry. Every batch is tested by the manufacturer for purity and concentration as part of routine quality control. Sourcing is direct — no intermediaries. Free shipping + customs clearance from $500 via specialist courier lanes.

Research Areas

Obesity & Energy Homeostasis

Preclinical work across incretin research examines food-intake regulation through hypothalamic POMC/AgRP pathways, gastric emptying kinetics, and adipose tissue metabolism. Rodent models of diet-induced obesity are the standard context for evaluating dose-dependent effects on body-weight trajectories.

Glucose & Cardiometabolic Endpoints

Studies of this compound class track glucose homeostasis, insulin secretion dynamics, and lipid parameters. Cardiovascular and renal endpoints have been added to longer-running programs, expanding the research scope beyond glycaemic control.

Quality & Testing

Testing methods include HPLC, LC-MS, endotoxins, heavy metals, sterility, water content, visible particulates, assay, impurities, and microbiology panels where applicable. Products are supplied against the specification shown on the applicable product page. The standard catalog purity specification is ≥98% unless otherwise stated. Product-specific specifications and quality-control information may vary by compound and batch. Batch documentation is available on request.

For laboratory research use only. Not for human or veterinary use. All products are sold exclusively for in vitro and preclinical research purposes.